Table 2.
Clinic pathologic factors associated with OS in the Cox hazard regression analysis for glioma patients from the CGGA dataset
Variable | Univariate Cox Regression | Multivariate Cox Regression | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Gender | 1.187 | 0.841–1.675 | 0.330 | |||
Age at diagnosis | 1.038 | 1.022–1.053 | < 0.001 | 0.998 | 0.979–1.018 | 0.875 |
WHO Grade | 3.469 | 2.709–4.443 | < 0.001 | 1.926 | 1.370–2.709 | < 0.001 |
ADAR3 expression | 0.356 | 0.284–0.447 | < 0.001 | 0.571 | 0.430–0.760 | < 0.001 |
MGMT promoter methylation | 0.529 | 0.374–0.750 | < 0.001 | 0.665 | 0.444–0.997 | 0.048 |
IDH1/2 Mutation status | 0.229 | 0.159–0.331 | < 0.001 | 0.637 | 0.370–1.097 | 0.104 |
Radiotherapy | 0.421 | 0.291–0.611 | < 0.001 | 0.409 | 0.276–0.606 | < 0.001 |
Chemotherapy | 1.386 | 0.969–1.983 | 0.074 |
P value < 0.05 was considered statistically significant
CI, confidence interval; HR, hazard ratio; IDH1/2, isocitrate dehydrogenase 1/2; MGMT, O6-methylguanine-DNA methyltransferase